This study describes an isocratic reversed phase high-performance liquid chromatographic method for the analysis of pyridinium cross links in serum, urine and dialysates obtained from patients with chronic renal failure on haemodialysis.
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The measurement of urine pyridinoline (pYD) and deoxypyridinoline (DPD) has proven to be a sensitive index of bone resorption. PYD is widely distributed, being found in major collagens, type 1 (bone) and type II (cartilage), but absent in type I collagen of the skin. DPD is less abundant, found mainly in bone and dentine, and appears to be a specific marker of bone collagen degradation.' PYD was initially isolated from urine samples, where it exists in free and peptide-bound forms. 2 The assay was facilitated by the development of a preliminary cellulose extraction for the isolation of desmosines" which removes the majority of polar f1uorophores. Many high-performance liquid chromatographic (HPLC) methods have been developed for the estimation of total PYD and DPD in urine. Black et al. 4 developed a similar gradient HPLC method to that of Eyre et al.,s using octane sulphonic acid as an ion pairing agent.
Analysis of urine pyridinium crosslinks has been used to monitor bone resorption in a Correspondence: Dr J L Barron. wide range of bone disease including malignant, endocrine, metabolic, arthritic" and renal disease," Robins et al. 8 were able to detect crosslinks in serum samples from patients with osteoarthritis but not in normal subjects, using a combination of gradient ion-paired reverse-phase HPLC and immunoassay. Applying an isocratic method, the presence of PYD was demonstrated in serum from normal and uraemic subjects." James et al. 9 described an improved isocratic ion paired reverse phase HPLC assay using narrow bore columns with high sensitivity fluorescence detection and demonstrated the possibility of measuring pyridinium crosslinks in biological fluids other than urine. This study evaluates the estimation of PYD and DPD in serum, urine and dialysate of patients with chronic renal failure on haemodialysis (HD).
MATERIALS AND METHODS

Study population
Nineteen (10 women and 9 men, age range 19-57 years) members of the laboratory staff were controls and 29 patients (13 women and 16 men, age range 23-81 years) in chronic renal failure on HD were studied. Twenty-four hour urines were collected in all except seven anuric patients. All subjects and patients gave informed consent for participation in the study and approval was obtained from the St Helier Hospital Ethics Committee. All reagents not specified were purchased from Sigma Chemical Company (poole, Dorset, UK).
Purification of pyridinium crosslinks standards
Standards of PYD and DPD were prepared from urine collected from a patient with Paget's disease. The method of isolation was modified from that of James et a/. 9 Briefly, 50 mL urine was hydrolysed in equal volumes of concentrated HCl at 115°C for 16 h in stoppered glass tubes. All tubes were centrifuged at 3000 g for 10 min, the clear hydrolysate pooled and mixed with equal volumes of glacial acetic acid, CFl cellulose (50J0) (Whatman International Ltd, Kent, UK) in butanolic eluent (4:1 :1, butan-l-ol : glacial acetic acid: water) and 360 mL butan-l-ol and loaded onto extraction columns.
Three columns (20 x 2 em) were prepared using 5% (w/v) CFl cellulose in butanolic eluent. The hydrolysate mixture was loaded onto the three columns. Each column was washed with 100 mL of butanolic eluent. The crosslinks were eluted with distilled water (50 mL each column) and collected in 10mL glass tubes. After centrifugation at 2000g for 10 min, the upper butanolic layer was carefully removed. Tubes containing the lower aqueous layer with the crosslinks, were frozen at -70°C and the samples were lyophilized, then each sample was resuspended in 500 ILL of O' 05 M HCl, pooled and re-purified using the above procedure.
The re-purified material was lypholized and suspended in 500 ILL of 0·05 M HCl. The mixture was centrifuged at 3500g for 15 min and the supernatant was filtered, aliquots placed into cryogenictubes and frozen at -70°C until required. The purified material was kindly standardized by Dr David Perrett (St Bartholomew's Hospital, London, UK) using an isocratic HPLC method." Extraction of crosslinks from serum and dialysate prior to HPLC Serum or dialysates (1 mL) were hydrolysed in equal volumes of concentrated HCl at 115°C for 16 h in stoppered glass tubes. Hydrolysate of the dialysate was centrifuged for 10 min to remove Ann Clin Biochem 1996: 33 debris but hydrolysates of serum were filtered using micro-filters (45 IL) (Millipore, Watford, UK) because the precipitate could not be removed by centrifugation. Aliquots (1 mL) were mixed with glacial acetic acid (0' 5 mL), CFl cellulose (0' 5 mL) in butanolic eluent and butan-L-ol (2 mL) in a glass tube prior to application to the extraction columns. A separation unit was designed with a collection rack enabling the simultaneous separation of 20 samples in duplicate. Cellulose CFl columns were prepared from 10 mL extraction columns and filled with 5 mL of 5% CFl cellulose in butanolic eluent. Samples were loaded onto the column and interfering fluorescent compounds were removed with a 15 mL wash of butanolic eluent. The crosslinks were eluted with distilled water (5 mL) and collected in a glass tube. After centrifugation at 2000g for 10 min, the upper butanolic layer was carefully removed. Tubes containing the lower aqueous layer with the crosslinks, were frozen at -70°C and freeze dried overnight. The lypholized samples were suspended in 250 ILL of 0·05 M HCl and 50 ILL was used for HPLC. Crosslinks were similarly extracted from urine. Analyses on urine extracts were performed using 20 ILL injections.
Sample coUection
Blood was collected from normal subjects and patients on HD (pre-and post-dialysis samples), centrifuged and serum aliquots were stored at -40°C until required. Dialysate samples were collected within 15 min of starting haemodialysis in 22 patients and stored at -20°C until required. Urine samples were collected for 24 h, acidified with 6 M HCl (20 mL) and aliquots were stored at -20°C until required.
An isocratic HPLC method was optimized as previously described.? Samples were separated on a 3 ILm ODS Apex II column (150x4·6mm) (Jones Chromatography Ltd, Glamorgan, UK). The mobile phase consisted of 25 mmollL sodium formate, 5 mmollL octane sulphonic acid, 1 mmollL EDTA, pH 3·25 plus 17% (v/v) methanol, with a flow rate of 1 mL/min at 40°C. The detector was a Shimadzu RF 535 fluorimeter (ex 290 nm, em 395 nm) (Dyson Instruments Ltd, Tyne and Wear, UK). The conditions were such that PYD and DPD eluted in under 10 min. All analyses were carried out in duplicate and three controls were used with each batch.
Urine, serum and dialysate creatinine were determined by a kinetic Jaffe method on a
RESULTS
Optimization of the analytical method Results showed that the fluorescence response for PYD and DPD was linear (r = 0 . 99) over the range investigated (PYD 2· 32-25 -5 pmoll20 /oiL injection; DPD 0-52-5'66 pmoV20 /oiL injection). Recovery studies performed by analysing five urine samples to which 300 nmollL of PYD and 68 nmollL of DPD had been added, showed the mean (SD) recovery was 103070 (2-3%) for PYD (range 100'3-104'4%) and 111-5% (3'3%) for DPD (range 108·3-114·9%). The intra-and inter-assay precision was similar using three different urine controls. The coefficients of variation were 2·4% (n = 5) and 5· 8% (n = 5) for PYD (21. 36 pmoll20 /oiL injection) and 3 . 9% and 6· 2% for DPD (4' 4 pmol120 /oiL injection), respectively. Figure 1 shows HPLC chromatograms of PYD and DPD in the serum from a patient.
DISCUSSION
At present most analyses for pyridinium crosslinks are done using urine, primarily due to the fact that concentrations in serum are below Pyridinium crosslink concentrations in controls and patients on haemodialysis The mean (SD) of urinary PYD/Cr and DPD/Cr ratio in nineteen normals was 28 -9 (6 -3) and 9· 1 (3. 6) /Lffiollmol, respectively, as shown in Table 1 . The correlation coefficient of PYD/Cr with DPD/Cr is O' 62 in control subjects and 0·99 in the patients. In normal subjects the mean serum PYD concentration was 5· 9 (l : 5) nmol/L but DPD was below the detection limit of the assay.
In the patients, urine PYD/Cr, 244' 6 {436'5)/oImol!mol and DPD/Cr, 66·5 {116'8)/olmollmol was significantly elevated compared to the volunteers (P=0-02). The crosslink concentrations in serum were significantly higher than normal volunteers and the concentrations in pre-dialysis samples were significantly higher (P<O'OOOI) (see Table 1 ).
The mean dialysate PYD/Cr ratio was 0·24 
Isolation and purification of PYD and DPD standards
The standard prepared from urine collected from a patient with Paget's disease had only PYD and DPD peaks on HPLC indicating acceptable purity.
Technicon Axon analyser (Bayer Diagnostics, Basingstoke, UK).
Statistical analysis
Excel software (Microsoft Corporation, Redmond, OR, USA) package was used for statistical analysis. Statistical significance of differences between normal subjects and the patients were determined by Student's t test and correlation coefficients were obtained by linear regression analysis. Descriptive statistics were determined for all the biochemical data.
Calculation of results
The concentrations of PYD and DPD in dialysate and 24 h urine were expressed as ratio to creatinine (p.mollmol), and as nmollL in serum. The concentration of the standard used as a reference was PYD 240 nmollL and DPD 53 nmollL. the detection limit for gradient HPLC methods. The measurement of cross links in serum is essential to determine the effect of chronic renal failure on bone resorption and the excretion of pyridinium crosslinks. In addition, the assay of crosslinks in serum may provide a better index of bone resorption compared to the urine pyridinium crosslinks-creatinine ratio, used to correct for urine flow rate and body mass. The isocratic HPLC method used in this study enabled the detection in serum of PYD in normal volunteers and both crosslinks in patients with chronic renal failure. There are preliminary reports that serum PYD and DPD were both measurable in normal subjects and uraemic patients.f-? but this is the first detailed determination of pyridinium crosslinks by HPLC in serum and dialysate. Recently, Abbiatti et al. I D described an improved clean-up procedure involving ultrafiltration of serum or plasma under centrifugation prior to hydrolysis. With this innovative step, they were able to quantify PYD and DPD in healthy volunteers and improve the detection limit of the assay to 60 fmollmL for both crosslinks. We are currently investigating the use of a newer fluorometer with lower baseline noise to signal ratio, with a sensitivity twenty times greater than that available for this study. Cellulose extraction removes the majority of fluorophores that could interfere with the detection of pyridinium crosslinks. The recovery of crosslinks in this study compares well with those reported in the literature.v '? Incomplete Ann Clin Biochem 1996: 33 loading or elution of the samples onto the cellulose column will lead to poor recoveries;"
Urine PYD and DPD are found in both peptide-bound and free forms in the ratio of 3:2 and hydrolysis is required in order to determine total urinary collagen crosslinks. The finding that free cross links was as effective in the assessment of bone resorption as total crosslinks,' led to the development of direct immunoassay methods for the estimation of free crosslinks in serum and urine." Recent data suggest that the ratio of free to peptide-bound crosslinks is relatively stable in normal and disease groups with good correlation between the twO. 14 The clinical significance of estimation of free crosslinks in patients with renal disease is yet to be established. The pre-renal and renal metabolism of the crosslinks has not been studied and the factors which determine the free to bound ratio are not known. One study has shown that the proportion of free to bound crosslinks is higher in women.l" but until all other factors are known, estimation of total crosslinks in serum or urine should be more diagnostically useful.
There are few reports of clinical utility of pyridinium crosslinks in renal disease. James et al,lS showed increased serum pyridinium crosslinks in uraemic patients. McL~ren et al. 16 reported that the pyridinium crosslinks are increased in renal patients but found that there was no correlation between creatinine clearance and the high concentrations of crosslinks in urines. This study shows that in patients on haemodialysis, both urinary and serum pyridinium crosslink concentrations are elevated above those of controls and that the crosslinks are detectable in the dialysate. The much lower PYD/Cr and DPD/Cr in dialysate, compared to urine, may be due to the timing of sampling and more rapid clearance of creatinine during dialysis. The decrease in serum PYD and DPD post dialysis suggests that in anuric patients, serum and dialysate concentrations of crosslinks may be useful in assessing the degree of bone resorption. However, the use of dialysate crosslinks needs further clinical evaluation and validation with bone biopsy, the gold standard in the assessment of renal osteodystrophy.
The results of this study confirm the usefulness of estimation of pyridinium crosslinks, PYD and DPD, as sensitive markers of bone collagen degradation in patients with renal osteodystrophy. There is no previous data regarding the levels of PYD or DPD in haemodialysis patients, with respect to age or disease activity. The determination of the pyridinium crosslinks in patients with chronic renal failure should prove to be a useful indicator of renal osteodystrophy. Further prospective studies to investigate the use of crosslinks in the management of renal patients are needed. The effect of treatment of renal patients with vitamin D analogues on the excretion of crosslinks needs to be investigated and should prove useful in the management of patients with renal disease and the prevention of renal bone disease.
